Kiwi Biosciences
YC S21 · Active · Patent-pending enzymes to break down common dietary triggers
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS22 | |
| Other | Active | YCS22 | |
| Other | Not stated | Antler2023 | |
| Other | Active | YCW23 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Not stated | Plug and Play | |
| AI, Devtools | Acquired | YCW23 | |
| AI | Not stated | Plug and Play | |
| Other | Active | YC +1S21 | |
| AI | Active | YCW23 |
Also from S21
All of S21About Kiwi Biosciences
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
- YC batch
- S21 · Summer 2021
- Status, per YC
- Active
- Category
- Other
- Team size
- 10
- Location
- Boston, MA, USA
- Checked
- 36m ago
Kiwi Biosciences: questions
Which YC batch was Kiwi Biosciences in?
Kiwi Biosciences was in Y Combinator's Summer 2021 batch (S21).
Is Kiwi Biosciences still active?
Y Combinator lists Kiwi Biosciences as active.
Where is Kiwi Biosciences based?
Kiwi Biosciences lists Boston, MA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.